Alan A Dombkowski Selected Research

Leukemia

9/2009	RUNX1 regulates phosphoinositide 3-kinase/AKT pathway: role in chemotherapy sensitivity in acute megakaryocytic leukemia.
2/2006	Differential gene expression, GATA1 target genes, and the chemotherapy sensitivity of Down syndrome megakaryocytic leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alan A Dombkowski Research Topics

Disease

5	Epilepsy (Aura) 07/2021 - 03/2016
4	Drug Resistant Epilepsy 07/2021 - 03/2016
4	Tuberous Sclerosis (Bourneville's Disease) 07/2021 - 03/2016
4	Neoplasms (Cancer) 01/2021 - 06/2010
4	Acute Megakaryoblastic Leukemia (Leukemia, Megakaryocytic) 01/2013 - 02/2006
4	Carcinogenesis 04/2011 - 09/2006
3	Down Syndrome (Down's Syndrome) 01/2013 - 02/2006
2	Inborn Genetic Diseases (Disease, Hereditary) 07/2021 - 03/2016
2	Seizures (Absence Seizure) 07/2021 - 03/2016
2	Breast Neoplasms (Breast Cancer) 09/2018 - 02/2011
2	Neoplasm Metastasis (Metastasis) 04/2011 - 02/2011
2	Leukemia 09/2009 - 02/2006
2	Esophageal Neoplasms (Esophageal Cancer) 08/2008 - 01/2008
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Neuroinflammatory Diseases 12/2019
1	Autism Spectrum Disorder 01/2018
1	Cognitive Dysfunction 01/2018
1	Neurologic Manifestations (Neurological Manifestations) 01/2018
1	Cholestasis 07/2015
1	Genomic Instability 02/2012
1	Inflammation (Inflammations) 04/2011
1	Papilloma (Papillomatosis) 04/2011
1	Lymphoma (Lymphomas) 06/2010
1	Adenocarcinoma 06/2010
1	Liver Cirrhosis (Hepatic Cirrhosis) 03/2010
1	Hepatocellular Carcinoma (Hepatoma) 03/2010
1	Liver Neoplasms (Liver Cancer) 03/2010
1	Breast Diseases (Breast Disease) 09/2006
1	Disease Progression 09/2006
1	Hemorrhage 12/2005

Drug/Important Bio-Agent (IBA)

6	MicroRNAs (MicroRNA)IBA 07/2021 - 02/2011
4	trans-sodium crocetinate (crocetin)IBA 07/2021 - 03/2016
4	Proteins (Proteins, Gene)FDA Link 03/2016 - 09/2006
3	nitrosobenzylmethylamineIBA 04/2011 - 07/2007
2	Biomarkers (Surrogate Marker)IBA 07/2021 - 01/2021
2	Glycoproteins (Glycoprotein)IBA 01/2021 - 02/2006
2	Transcription Factors (Transcription Factor)IBA 01/2013 - 03/2010
2	Folic Acid (Vitamin M)FDA LinkGeneric 02/2012 - 06/2010
1	Untranslated RNA (Noncoding RNA)IBA 07/2021
1	Polysaccharides (Glycans)IBA 01/2021
1	GlycolipidsIBA 01/2021
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2019
1	NexusIBA 06/2018
1	Tryptophan (L-Tryptophan)FDA Link 01/2018
1	Tuberous Sclerosis Complex 1 ProteinIBA 03/2016
1	EnzymesIBA 07/2015
1	Bile Acids and Salts (Bile Acids)IBA 07/2015
1	Matrix Metalloproteinases (MMPs)IBA 04/2011
1	CarbohydratesIBA 04/2011
1	Lipoxygenase (Lipoxygenase-1)IBA 04/2011
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2011
1	Messenger RNA (mRNA)IBA 04/2011
1	Arachidonic Acid (Vitamin F)IBA 04/2011
1	DNA Polymerase beta (DNA Polymerase IV)IBA 06/2010
1	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 06/2010
1	MEF2 Transcription FactorsIBA 03/2010
1	Hormones (Hormone)IBA 03/2010
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 09/2009
1	phenethyl isothiocyanate (PEITC)IBA 08/2008
1	CarcinogensIBA 01/2008
1	Bone Marrow Stromal Antigen 2IBA 02/2006
1	ProdrugsIBA 12/2005
1	Blood Coagulation Factors (Coagulation Factor)IBA 12/2005
1	PlasminogenIBA 12/2005

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2013 - 02/2006
2	Therapeutics 09/2018 - 01/2011
1	Chemoprevention 09/2006
1	Thrombolytic Therapy 12/2005